Synopsis :

Chandan Healthcare partners exclusively with Jeena Sikho Lifecare to provide nationwide pathology and radiology services, enhancing affordable, technology-driven diagnostics and expanding Chandan’s presence across India’s healthcare network.

During Friday’s trading session, shares of a company running diagnostic centres in North India with pathology and radiology testing services hit a 5 percent upper circuit on NSE, after the company announced entering into a strategic partnership with Jeena Sikho Lifecare Limited to establish diagnostic centres.

With a market cap of Rs. 704 crores, the shares of Chandan Healthcare Limited hit a 5 percent upper circuit to a new 52-week high at Rs. 288 on NSE, as against its previous closing price of Rs. 274.3.

What’s the News

Accordin

See Full Page